Encompass Health Corporation (EHC) Stock

About Encompass Health Corporation

Encompass Health Corporation is led by CEO Mark J. Tarr, employs 42,300 people, headquartered in Birmingham, US, publicly traded since 1986.

Encompass Health Corporation (EHC) stock trades at $124.09 with a market capitalization of $12.24B. The stock is valued at a price-to-earnings (P/E) ratio of 19.26, price-to-book of 4.56, price-to-sales of 1.91. Over the past 52 weeks the stock has ranged between $92.77 and $128.27, and currently trades 3.3% below its 52-week high. It pays a dividend yielding 0.70%.

On profitability, Encompass Health Corporation generates a return on equity (ROE) of 25.01%, above the typical market range of roughly 12-15%, return on capital employed of 16.97%, an operating margin of 17.74%, a net profit margin of 10.01%.

Encompass Health Corporation by the numbers, 2016–2025

Between 2016 and 2025 Encompass Health Corporation reported revenue of $3.6B rising to $5.9B, a change of +62.9% across 10 years. Compounded, revenue has grown 10.7% a year over five years, 10.9% over three, 10.5% over the last twelve months. Net profit rose to $566.0M.

Operating margin went from 17.8% in 2016 to 17.7% in 2025, essentially unchanged. The most recent net margin is 10.01%. On a trailing twelve-month basis to Jun '26, revenue is $6.2B and net profit $622.0M.

Borrowings fell from $3.0B to $2.7B, cash from operations was $1.2B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 21.8% over five years, and was 23.2% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Encompass Health Corporation (EHC) — frequently asked questions